thymia

thymia is a pioneering deep tech company based in London that develops regulated voice biomarkers for healthcare. Their world-leading AI models detect depression, anxiety, and all 15 core mental health symptoms with clinical-grade accuracy through just 15 seconds of speech. Recent breakthroughs have expanded their capabilities into physical health screening, including detection of COPD, hypertension, and type 2 diabetes.

Through safe and secure voice AI agents that integrate seamlessly into any point of the patient pathway, thymia transforms waiting time into valuable screening and monitoring time, improving triage efficiency, reducing waiting times, supporting social prescribing pathways, and reducing clinician burden. Already trusted by NHS partners and leading pharmaceutical companies including Bayer and UCB Pharma, thymia is now launching the fastest and most advanced speech biomarker engine across the NHS, empowering clinicians to focus their expertise where it’s needed most.